Encore Capital Group just delivered its strongest earnings surprise in recent memory — and the options market had already started moving the other direction before the print landed.
Q1 EPS came in at $3.86, against a consensus estimate of $3.02. That is a 28% beat. Sales of $475.4 million also topped the $445.6 million estimate. Management then raised full-year 2026 GAAP EPS guidance to $13.00 from $12.00, against an analyst estimate of $11.90. For a consumer finance name trading at a PE of 6.8x, that guidance lift is meaningful — it puts forward earnings power clearly above what the Street had modelled even last week. The stock gained 1.5% on May 5 and has recovered 18.6% over the past month.
The options market has pivoted sharply in the past week, and the direction is worth noting. ECPG's put/call ratio dropped to 2.96 on May 5 — well below its 20-day average of 4.07 and nearly three standard deviations below that mean. A PCR near 3 still reads as heavily put-skewed in absolute terms, but the direction of travel is unmistakably toward calls. One month ago the PCR was running above 5.6, near its 52-week high. Traders have been unwinding put protection into the earnings event, not adding it — a shift that aligns with the stock's sharp re-rating.
Short positioning has been building over the past month yet tells a cautious story rather than an aggressive one. Short interest is 5.1% of the free float — up roughly 13% in the past 30 days, meaning some fresh shorts were added into the rally. The week-on-week trend reversed, however, with SI dipping 2.2% in the five sessions through May 5. Borrow availability is loose. Cost to borrow is just 0.44% annualised, down nearly 20% over the past month, and the lending pool is well-supplied. There is no squeeze dynamic at work here: short sellers can add or exit easily.
The analyst community has been positive but the most recent price-target revisions are from late February 2026, when both Citizens and Truist Securities raised targets after the prior earnings beat — to $90 and $80 respectively. With the stock at $84.41 today and a fresh guidance raise just filed, the mean target of $96.67 now carries more credibility than it did a week ago. The valuation case supports the bulls: PE of 6.8x and EV/EBITDA near 8.5x are undemanding for a business earning $3.86 per quarter. EPS surprise ranks in the 93rd percentile of the universe, and the 90-day EPS momentum score is in the 98th — both reflect a streak of consistent outperformance. The 30-day forward EPS increase score is just 11, however, suggesting estimate upgrades for the next year have not yet followed the guidance raise; that revision cycle could be the next catalyst.
Institutional ownership is stable and concentrated. BlackRock holds 18.5% of shares, Vanguard a further 11.1%. Goldman Sachs Asset Management added 73,000 shares in Q1 2026. Turtle Creek, a more active manager, trimmed nearly 977,000 shares in the December quarter — a meaningful reduction given their prior position. That exit was at significantly lower prices than today, and its absence from more recent filings makes it a historical data point rather than a live signal.
Insider activity from early March is the one muted note. CEO Ashish Masih sold 25,658 shares at $68.19 and received compensatory awards the same day — a routine vest-and-sell rather than an outright conviction trade. The net 90-day insider position is actually positive at around $3.9 million, driven by award mechanics. Nothing in the insider ledger reads as a warning.
The next print is scheduled for June 12. Between now and then, what matters most is whether Wall Street analysts lift their price targets and 2026 estimates to reflect the new guidance band — and whether the PCR continues its drift back toward a more neutral reading as post-earnings put protection unwinds.
See the live data behind this article on ORTEX.
Open ECPG on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
